Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Basset

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
American Journal of Hematology|April 12, 2021
Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21Christoph R Kimmich, Tobias Terzer, Axel Benner, et al.
British Journal of Haematology|August 3, 2021
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-upMarco Basset, Christoph R Kimmich, Nicholas Schreck, et al.
American Journal of Hematology|July 1, 2020
Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progressionMarco Basset, Kamal Hummedah, Christoph Kimmich, et al.
Blood Advances|February 20, 2025
Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort studyAmy Song, George Mellgard, Claudia Bellofiore, et al.
Clinical Chemistry and Laboratory Medicine|January 12, 2022
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patientsMarco Basset, Paolo Milani, Virginia Valeria Ferretti, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 28, 2020
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosisRiccardo Caccialanza, Emanuele Cereda, Catherine Klersy, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 2017
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assaysGiovanni Palladini, Arnaud Jaccard, Paolo Milani, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosisFrancesca Russo, Veronica Valentini, Marco Basset, et al.
Blood|June 8, 2019
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patientsMasayoshi Tasaki, Paolo Milani, Andrea Foli, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 4, 2025
Left ventriculo-arterial coupling in a contemporary cohort of patients with wild-type transthyretin cardiac amyloidosis treated with tafamidisGiuseppe Damiano Sanna, Valeria Anna Di Simone, Paolo Milani, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
American Journal of Hematology|April 12, 2021
Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21Christoph R Kimmich, Tobias Terzer, Axel Benner, et al.
British Journal of Haematology|August 3, 2021
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-upMarco Basset, Christoph R Kimmich, Nicholas Schreck, et al.
American Journal of Hematology|July 1, 2020
Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progressionMarco Basset, Kamal Hummedah, Christoph Kimmich, et al.
Blood Advances|February 20, 2025
Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort studyAmy Song, George Mellgard, Claudia Bellofiore, et al.
Clinical Chemistry and Laboratory Medicine|January 12, 2022
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patientsMarco Basset, Paolo Milani, Virginia Valeria Ferretti, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 28, 2020
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosisRiccardo Caccialanza, Emanuele Cereda, Catherine Klersy, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 2017
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assaysGiovanni Palladini, Arnaud Jaccard, Paolo Milani, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosisFrancesca Russo, Veronica Valentini, Marco Basset, et al.
Blood|June 8, 2019
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patientsMasayoshi Tasaki, Paolo Milani, Andrea Foli, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 4, 2025
Left ventriculo-arterial coupling in a contemporary cohort of patients with wild-type transthyretin cardiac amyloidosis treated with tafamidisGiuseppe Damiano Sanna, Valeria Anna Di Simone, Paolo Milani, et al.
Pageof 6